168 related articles for article (PubMed ID: 6429397)
1. Combination of hepatic arterial infusion and systemic chemotherapy for gastric cancer with synchronous hepatic metastases.
Kano T; Kumashiro R; Abe Y; Notsuka T; Tamada R; Inokuchi K
Jpn J Surg; 1984 Jan; 14(1):23-9. PubMed ID: 6429397
[TBL] [Abstract][Full Text] [Related]
2. Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Seki H; Ohi H; Ozaki T; Yabusaki H
Acta Radiol; 2016 Jul; 57(7):781-8. PubMed ID: 26339040
[TBL] [Abstract][Full Text] [Related]
3. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
4. [Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment].
Kitamura M; Arai K; Miyashita K; Kosaki G
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2936-9. PubMed ID: 2506831
[TBL] [Abstract][Full Text] [Related]
5. [A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer].
Arai Y; Endo T; Miyake Y; Sakamoto K; Kido C
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2731-4. PubMed ID: 2782885
[TBL] [Abstract][Full Text] [Related]
6. [Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer].
Mori N; Hamada H; Nakamura T; Tanaka A; Nakajima I; Nakamura Y; Wada T; Yasutomi M
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3473-6. PubMed ID: 2508570
[TBL] [Abstract][Full Text] [Related]
7. [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
Aoyagi K; Koufuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1678-81. PubMed ID: 15553681
[TBL] [Abstract][Full Text] [Related]
8. [Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C].
Sasaki Y; Sasaki J; Ito T; Nehashi Y
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2793-5. PubMed ID: 3137891
[TBL] [Abstract][Full Text] [Related]
9. [5-FU/ADR/MMC combined hepatic infusion in liver metastases from gastric cancer].
Arai Y; Kido C; Endo T; Miyake Y; Sato Y; Ozawa H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2433-6. PubMed ID: 3415254
[TBL] [Abstract][Full Text] [Related]
10. [Over two years survival of intra-arterial infusion chemotherapy in gastric cancer with liver metastases].
Okuyama K; Onoda S; Tohnosu N; Koide Y; Awano T; Ozaki M; Ochiai T; Gunji Y; Matsubara H; Kinoshita H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2932-5. PubMed ID: 2506830
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil.
Fujimoto S; Miyazaki M; Endoh F; Takahashi O; Okui K; Morimoto Y
Cancer; 1985 Nov; 56(10):2404-10. PubMed ID: 2412682
[TBL] [Abstract][Full Text] [Related]
12. [A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Matsuoka K; Hisamatsu T; Aoyagi S; Motohashi Y; Ikezawa T; Tatsuno S; Mizuno Y; Nishida J
Gan To Kagaku Ryoho; 2001 Feb; 28(2):243-6. PubMed ID: 11242655
[TBL] [Abstract][Full Text] [Related]
13. Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases.
Yonemura Y; Matuki N; Sakuma H; Katayama K; Sawa T; Fujimura T; Ohyama S; Miwa K; Miyazaki I; Tanaka M
Surg Today; 1992; 22(3):253-9. PubMed ID: 1392330
[TBL] [Abstract][Full Text] [Related]
14. [Preventive hepatic arterial infusion in high risk cases of liver metastasis from gastric cancer].
Takahashi Y; Mai M; Fujimoto T; Ohta T; Ueda H; Ogino T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2756-9. PubMed ID: 2506821
[TBL] [Abstract][Full Text] [Related]
15. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer].
Nashimoto A; Tsuchiya Y; Sasaki J; Sano M; Tanaka O; Tsutsui M; Makino H
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1402-5. PubMed ID: 9703839
[TBL] [Abstract][Full Text] [Related]
17. 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.
Pernot S; Velut G; Kourie RH; Amouyal G; Sapoval M; Pointet AL; Landi B; Zaimi Y; Lepère C; Pellerin O; Taieb J
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):255-260. PubMed ID: 29233520
[TBL] [Abstract][Full Text] [Related]
18. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Kusunoki M; Yanagi H; Noda M; Yoshikawa R; Yamamura T
Cancer; 2000 Sep; 89(6):1228-35. PubMed ID: 11002217
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
Shitara K; Munakata M; Kudo T; Kasai M; Muto O; Okada R; Mitobe S; Ishiguro A; Sakuraba H; Ikami I; Sakata Y
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2033-7. PubMed ID: 17197748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
